Related Experiment Video
Updated: May 18, 2026

An In Vitro Enzymatic Assay to Measure Transcription Inhibition by Gallium(III) and H3 5,10,15-tris(pentafluorophenyl)corroles
Published on: March 18, 2015
Inhibition of transcription by platinated triplex-forming oligonucleotides
Mindy K Graham1, Paul S Miller
1Department of Biochemistry and Molecular Biology, Johns Hopkins Bloomberg School of Public Health, 615 North Wolfe Street, Baltimore, MD 21212, USA.
Abstract:
Platinated triplex-forming oligonucleotides (TFOs) consisting of 2'-methoxythymidine and 2'-methoxy-5-methylcytidine and an N-7 platinated deoxyguanosine ((Pt)G) at the 5'-((Pt)G-TFO), 3'-(TFO-G(Pt)), or 3'- and 5'-((Pt)G-TFO-G(Pt)) ends of the TFO form mono-((Pt)G-TFO and TFO-G(Pt)) and interstrand ((Pt)G-TFO-G(Pt)) cross-links with target DNA as a result of reaction of the (Pt)G with guanines adjacent to the homopurine TFO binding site in the target. The extent of cross-linking is greatest when the (Pt)G is located on the 3' end of the TFO and the target guanine is on the same strand as the TFO binding site. Multiple, contiguous deoxyguanosines in the TFO binding site or a cytosine adjacent to the G(Pt) of the TFO significantly reduce cross-linking. DNA reporter plasmids in which platinated TFOs were cross-linked at a site in the transcribed region between a CMV promoter and a luciferase reporter gene were transfected into Chinese hamster ovary cells, and luciferase expression was compared with that for the corresponding non-cross-linked plasmid. Luciferase expression was inhibited 95 % when TFO-G(Pt) was bound and cross-linked to the transcribed strand, demonstrating that the cross-linked TFO was able to block transcription elongation. Further inhibition (99 %) was observed in nucleotide excision repair (NER) deficient cells, suggesting that NER may repair this lesion. The 3'-G(Pt) group of TFO-G(Pt) protects the TFO from degradation by exonucleases found in mammalian serum. Taken together, these results suggest that platinated TFOs of the type TFO-G(Pt) may find applications as agents for suppressing DNA transcription and consequently inhibiting gene expression in mammalian cells.
Insights
Platinated triplex-forming oligonucleotides (TFOs) can block DNA transcription and gene expression. These TFOs show potential for therapeutic applications by inhibiting gene activity in mammalian cells.
Area of Science:
- Medicinal Chemistry
- Molecular Biology
- Biochemistry
Background:
- Triplex-forming oligonucleotides (TFOs) are short DNA strands that bind to specific DNA sequences.
- Platination of TFOs introduces platinum-based cross-links to target DNA.
- Understanding TFO-DNA interactions is crucial for developing gene-targeting therapies.
Purpose of the Study:
- To investigate the cross-linking efficiency of platinated TFOs with target DNA.
- To evaluate the impact of platinated TFOs on gene transcription and expression.
- To assess the role of DNA repair mechanisms in response to platinated TFOs.
Main Methods:
- Synthesis of platinated TFOs with platinum at various positions.
- DNA cross-linking assays to determine binding and linkage efficiency.
- Transfection of DNA reporter plasmids into mammalian cells (CHO).
- Luciferase gene expression assays to measure transcriptional inhibition.
- Comparison of gene expression in normal versus nucleotide excision repair (NER) deficient cells.
Main Results:
- Platinated TFOs form mono- and interstrand cross-links with target DNA, with greatest efficiency at the 3' end.
- Cross-linking is reduced by contiguous guanines in the TFO binding site or adjacent cytosines.
- Platinated TFOs significantly inhibit transcription elongation, reducing luciferase expression by up to 95%.
- NER-deficient cells showed higher inhibition (99%), suggesting NER repairs the lesion.
- The 3'-G(Pt) moiety protects TFOs from serum exonuclease degradation.
Conclusions:
- Platinated TFOs, particularly TFO-G(Pt), effectively cross-link target DNA and inhibit transcription.
- These findings suggest platinated TFOs can be developed as gene expression inhibitors.
- The 3'-G(Pt) modification enhances TFO stability and therapeutic potential.
Related Concept Videos
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Transcription Attenuation in Prokaryotes
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
Inhibitors of Bacterial DNA Synthesis
Types of RNA
RNA Performs Diverse...
Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
RNA Polymerase II Accessory Proteins

